Failed in phase 2
Curcumin: reduce relapses and new lesions in relapsing MS
relapsing MS · Vitamin D and nutritional supplements
Controlled phase 2 trials did not meet their main goal for this group.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 80
How the verdict was reached
Negative in phase 2
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| CONTAIN | Phase 2 | 80 | 2012 | Missed its main goal | Counted |
Counted: 1. Will count later: 0. Not counted: 0.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Failed in phase 2
Related hypotheses
- Vitamin D and nutritional supplements: protect nerve tissue in relapsing MS
- Fish oil: protect nerve tissue in relapsing MS
- Melatonin: protect nerve tissue in relapsing MS
- Fish oil: repair myelin in relapsing MS
- Vitamin D and nutritional supplements: slow disability worsening in relapsing MS
- Cholecalciferol: slow disability worsening in relapsing MS
- Ergocalciferol: slow disability worsening in relapsing MS
- Fish oil: slow disability worsening in relapsing MS
- Melatonin: slow disability worsening in relapsing MS
- Retinol: slow disability worsening in relapsing MS
- Vitamin D and nutritional supplements: reduce relapses and new lesions in relapsing MS
- Cholecalciferol: reduce relapses and new lesions in relapsing MS
- Fish oil: reduce relapses and new lesions in relapsing MS
- Melatonin: reduce relapses and new lesions in relapsing MS
- Omega-3 fatty acids: reduce relapses and new lesions in relapsing MS
- Retinol: reduce relapses and new lesions in relapsing MS
Assembled by software from public sources.